Cannabis Investor NewsSubscribe →
C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
— —

Tilray Brands

—
—
Live Price

CIN RESEARCH · DATED EVIDENCE

Dated financial evidence

Tilray Brands: review the dated company evidence.

The reported-period revenue series records USD 257.15m for the period ended August 31, 2026.

Latest financial observation 2026-08-31Last reported price 2026-11-04Research checked 2026-11-04 13:30 UTC

The check time records a research refresh. Each financial figure and price keeps its own reporting date.

Start with the latest dated revenue

The reported-period revenue series records USD 257.15m for the period ended August 31, 2026.

Revenue and profitability are separate

The matching reported-period net loss is USD 43.14m. This is the reported result for 2026-08-31, not a future earnings estimate.

Cash is a dated balance

Cash was USD 214.96m at 2026-08-31. A matching, unit-consistent operating cash-flow period was not available, so no runway estimate is presented.

Follow the primary disclosures

The available record includes 2 primary disclosures. The latest is 2026-06-30. This is the available feed record, not a claim of complete filing coverage.

Reported financial evidence

Latest retained observation for each measure. Reporting periods and currencies can differ.
MeasureReported value & unitPeriod & intervalEvidence basis
RevenueUSD 257.15mUnit: USDReporting interval not specifiedPrimary report recordReported 2026-10-08
Cost of revenueUSD 179.64mUnit: USDReporting interval not specifiedPrimary report recordReported 2026-10-08
Gross profitUSD 77.51mUnit: USDReporting interval not specifiedPrimary report recordReported 2026-10-08
Operating incomeUSD -24.05mUnit: USDReporting interval not specifiedPrimary report recordReported 2026-10-08
Net incomeUSD -43.14mUnit: USDReporting interval not specifiedPrimary report recordReported 2026-10-08
Cash balanceUSD 214.96mUnit: USDBalance at period endPrimary report recordReported 2026-10-08
Total assetsUSD 2.33bnUnit: USDBalance at period endPrimary report recordReported 2026-10-08
Total liabilitiesUSD 721.28mUnit: USDBalance at period endPrimary report recordReported 2026-10-08
Shareholders’ equityUSD 1.62bnUnit: USDBalance at period endPrimary report recordReported 2026-10-08

A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.

What to investigate next

  • Read the latest linked company disclosures and any reporting after the financial period.
  • Check post-period financing, share issuance and changes in cash before drawing a current valuation conclusion.

Evidence boundaries

  • The supplied filing history does not establish the duration of some flow figures. Those values are not annualized or compared as quarters.
  • The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.

Primary company disclosures

Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →

Price History · USD 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

CONTINUE YOUR RESEARCH

Connect the next piece.